🎗️ Cervical Cancer FIGO 2018 Stage
Assign the FIGO 2018 cervical cancer stage from local extent, nodal status, adjacent-organ and distant spread, with a stage-specific management direction. Instant, browser-side.
Cervical Cancer FIGO 2018 Stage
Local tumour extent
Nodal metastasis (imaging r or pathology p)
Bladder/rectal mucosa or beyond true pelvis
Distant metastasis
When to use
Staging and first-line management direction for cervical cancer using the FIGO 2018 system (which incorporates imaging and pathology).
How it works
Highest level of involvement defines the stage: IA microscopic (≤ 3 / > 3–5 mm) → IB by size (≤ 2 / 2–4 / > 4 cm); II beyond uterus (IIA vagina / IIB parametria); III lower vagina (IIIA), pelvic wall/hydronephrosis (IIIB), pelvic nodes (IIIC1) / para-aortic (IIIC2); IVA mucosa/beyond pelvis, IVB distant.
Key points
- A key 2018 change: any nodal metastasis (any size, imaging r or pathology p) upstages to IIIC, recorded with an r/p notation.
- IB is subdivided by size (≤ 2 / > 2–4 / > 4 cm) into IB1/IB2/IB3 — a 2018 refinement over the older IB1/IB2 split.
- Early disease (≤ IIA1) is mainly surgical; IB3 and locally advanced disease are mainly concurrent platinum chemoradiation + brachytherapy.
- Fertility-sparing options exist for selected IA–IB1 disease.
References
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.